One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
GEC-ESTRO ACROP prostate brachytherapy guidelines
AnnHenryaBradley R.PietersbFrankAndré SiebertcPeterHoskindeon behalf of the UROGEC group of GEC ESTRO with endorsement by the European Association of Urology1
Chemoradiotherapy with temozolomide vs. radiotherapy alone in patients with IDH wild-type and TERT promoter mutation WHO grade II/III gliomas: A prospective randomized study
XiaoguangQiua1YidongChend1ZhaoshiBaobcLiChenaTaoJiangbc
Re-irradiation for recurrent high grade glioma (HGG) patients: Results of a single arm prospective phase 2 study
PierinaNavarriaaFedericoPessinabeElenaClericiaLuisaBelluaCiroFranzeseaeAndreaFranzinibMatteoSimonelliceLorenzoBellohArmandoSantoroceLetterio SalvatorePolitideGiuseppe RobertoD'agostinoaAlessandraCasarottibBethaniaFernandesfValterTorrigMartaScorsettiae
Urethral and bladder dose–effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial
Veerle H.GroenaMarcelvan SchiebNicolaas P.A.ZuithoffcEvelyn M.MonninkhofcMartinaKunze-BuschdJohannes C.J.de BoeraJochemvan der Voort van ZijpaFloris J.PosbRobert JanSmeenkdKarinHaustermanseSofieIsebaerteCédricDraulanseTomDepuydteHelena M.VerkooijenfUulke A.van der HeidebLinda G.W.Kerkmeijerad
Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)
GovindarajGanesanaSasipriyaPonniahaVivekSundarambPraveen KumarMarimuthuaVenkatramanPitchaikannuaManikandanChandrasekaranaJanakiramanThangarasucGunasekaranKannupaiyanaPrabhuRamamoorthyaBrindhaThangarajaHarshavardhanan SasipriyaGovindarajaShree VaishnaviRagurama
Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy
Ting MartinMaaJackNeylonaMariaCasadoaSahilSharmaaKeShengaDanielLowaYingliYangaMichael L.SteinbergaJamesLambaMinsongCaoa1Amar U.Kishanab1
LITE SABR M1: A phase I trial of Lattice stereotactic body radiotherapy for large tumors
SaiDurisetiJames A.KavanaughJeffSzymanskiYiHuangFrancoBasarabescuAadelChaudhuriLaurenHenkePamelaSamsonAlexanderLinCliffordRobinsonMatthew B.Spraker
Current practice in proton therapy delivery in adult cancer patients across Europe
MakbuleTambasaHans Paulvan der LaanaRoel J.H.M.SteenbakkersaJeromeDoyenbBeateTimmermanncdEsterOrlandieMortenHoyerfKarinHaustermansgPetraGeorghNeil GBurnetiVincentGregoirejValentinCalugarukEsther G.C.TroostlmnopqrFrankHoeberssFelipe A.CalvotJoachimWidderuFabianEberlevMarcovan Vulpenw…Johannes A.Langendijka
Implementation of MR-linac and proton therapy in two radiotherapy departments in The Netherlands: Recommendations based on lessons learned
MariaJacobsaLindaKerkmeijerbDirkde RuysschercEllenBrunenbergbLiesbethBoersmacMarcelVerheijb
Men’s preferences for image-guidance in prostate radiation therapy: A discrete choice experiment
AmyBrownabTilleyPainabAlexTanabLuxAnableaEmilyCallandercbKerrianneWattbDeborahStreetdRichardDe Abreu Lourencod
Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian study
JessicaChanabErikaBrowncKristopherDennisdMichaelMiloseviceMichaelBrundagef
Post-operative re-irradiation with hyperthermia in locoregional breast cancer recurrence: Temperature matters
AkkeBakkera1C. PaolaTello Valverdea1Geertjanvan TienhovenaM. WillemijnKolffaH. PetraKokaBen J.SlotmanaInge R.H.M.KoningsbArlene L.OeiacHester S.A.OldenburgdEmiel J.T.RutgersdCoen R.N.RascheH.J.G. Desiréevan den Bongarda2HansCrezeea2
Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma – How safe are protons?
Semi B.HarrabiabcdeBastianvon NettelbladtacdClemensGuddenaSebastianAdebergacdKatharinaSeidensaalacdJuliaBauerbcdEmanuelBahnacdeAndreaMairanibgMarkusAlberacdThomasHabererbJuergenDebusabcdefKlausHerfarthabcd
Non-invasive preoperative imaging differential diagnosis of pineal region tumor: A novel developed and validated multiparametric MRI-based clinicoradiomic model
YanghuaFan1XuleiHuo1XiaojieLiLiangWangZhenWu
Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study
Jannet C.Beukemaa1Crystalde Grootb1John T.M.PlukkercRozemarijnVliegenthartdJohannes A.LangendijkaPetervan LuijkaJoost P.van MelleeNiek H.J.PrakkendChristina T.Muijsa
Collagen score in the tumor microenvironment predicts the prognosis of rectal cancer patients after neoadjuvant chemoradiotherapy
XiaoyuDongab1YingHuangc1XianYua1MingjinHuangcWeiJiangaDexinChenaGuangxingWangbShuangmuZhuobPanChicJunYana
An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer
SaadSheikhaHanboChenbArjunSahgalbIanPoonbDarbyErlerbSerenaBadellinocRoiDagandMatthew C.FooteeAlexander V.LouiebKristin J.RedmondfUmbertoRicardicTithiBiswasa
Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG)
D.MartinabcT.SchreckenbachdP.ZieglerbceN.FilmannfG.KalinauskaiteghI.TinhoferghV.BudachghC.GaniijD.ZipsijT.Schimek-JaschklH.SchäferklA.L.GrosuklE.ThomasmnoprM.KrausemnopqrH.DapperstS.CombsstC.HoffmannuvM.Stuschkeuv…E.Fokasabc
Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: A nationwide population-based analysis
Rosanne C.Schoonbeeka1Dominique V.C.de Jelbc1Boukje A.C.van DijkdeStefan M.WillemsfElisabethBloemenagFrank J.P.HoebershEsthervan MeerteniBerit M.VerbistjLudi E.SmeeleckGyörgy B.HalmosaMatthias A.W.MerkxdlSabineSieslingdmRemcoDe BreenRobert P.Takesoon behalf of the Dutch Head, Neck Society, the COVID, Cancer-NL consortium
Relationship between oral mucositis and the oral bacterial count in patients with head and neck cancer undergoing carbon ion radiotherapy: A prospective study
AtsushiMushaab1ChikaHiraiaYokoKitadaaAnnaTsunodaaHirofumiShimadaaNobuteruKuboaHidemasaKawamuraaNaokoOkanoaHiroSatoaKoheiOkadaaAkikoAdachiaSatoshiYokoobKazuakiChikamatsucTatsuyaOhnoa
Incidence and prognostic significance of extranodal extension in isolated nodal recurrence of oral squamous cell carcinoma
Chun-WeiChangaChiWangbChi-JuLucChun-WeiWangdChen-TuWuefCheng-PingWangaTsung-LinYangaPei-JenLouaJenq-YuhKoaYih-LeongChangefTseng-ChengChena
Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial
Si-QiTanga1LeiChena1Wen-FeiLia1Anthony T.C.ChanbShao HuiHuangcMelvin L.K.ChuadeBrianO'SullivancAnne W.M.LeefgNancy Y.LeehYuanZhangaYu-PeiChenaChengXuaYingSunaLing-LongTangaJunMaa
Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline
QiaojuanGuoabc1NanXiaoa1HanchuanXuaJingfengZongaYoupingXiaodTianzhuLueYunXuaBingyiWangaBijuanChenaJianjiPanabShaojunLinab
Impact of salvage radiotherapy on survival of patients with advanced locally recurrent nasopharyngeal carcinoma: Derivation and validation of a predictive model
TingLiuab1Bo-WenShenc1Li-TingLiuab1Zhen-ChongYangab1Shi-QianWangc1Da-FengLinabXue-SongSunabShan-ShanGuoabSai-LanLiuabMei-JuanLuoabQiu-YanChenabLin-QuanTangabHai-QiangMaiab
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy
ShivaprasadPatilaij1BouchraTawkfuvwx1MarianneGrossermFabianLohausaiklVolkerGudziolnoMaxKemperlnAlexanderNowaklpDominikHaimlpIngeTinhoferbqVolkerBudachbqMajaGuberinacrMartinStuschkecrPanagiotisBalermpasdsClausRödeldsHenningSchäferetAnca-LigiaGrosuetAmirAbdollahifuvwxJürgenDebusfuvwy…AnnettLingeaikl2
Comparison and quantification of different concurrent chemotherapy regimens with radiotherapy in locally advanced non-small cell lung cancer: Clinical outcomes and theoretical results from an extended LQ and TCP model
XinLeiAiacd1BoQiuacdef1YinZhougSuLibcdQiWenLiacdefJianHuanhJiBinLibcdNanHuacdNaiBinChenacdFangJieLiuacdDaQuanWangacdChuChuacdBinWangacdLiChenacdHaiHangJiangiShiYuHuangjXiaoYanHuangacdNanBikHuiLiuacdef
ProCaLung – Peer review in stage III, mediastinal node-positive, non-small-cell lung cancer: How to benchmark clinical practice of nodal target volume definition and delineation in Belgium
FlorianCharlieraThomasDescampsaYolandeLievensbXavierGeetscVincentRemouchampsdMaartenLambrechteLuigiMorettia
Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy
KeaTurnera1Naomi C.Brownsteinb1ZacharyThompsonbIssamEl NaqacYiLuocHeather S.L.JimaDana E.RollisondRachelHowardeDesmondZengfStephen A.RosenbergghBradfordPerezghAndreasSaltoshLaura B.OswaldaBrian D.GonzalezaJessica Y.IslamdAmir AlishahiTabrizaWenbinZhangiThomas J.Dillinggh
Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab
MariaThoraAnnemarie F.ShepherdbIsabelPreeshagulcMichaelOffincDaphna Y.GelblumbAbraham J.WubAdityaApteaCharles B.SimoneIIbMatthew D.HellmanncAndreasRimnerbJamie E.ChaftcDaniel R.GomezbJoseph O.DeasyaNarekShaverdianb
On the interplay between dosiomics and genomics in radiation-induced lymphopenia of lung cancer patients
SerenaMontiaTingXubZhongxingLiaobRadheMohancLauraCellaaGiuseppePalmaad
Contouring cardiac substructures on average intensity projection 4D-CT for lung cancer radiotherapy: A proposal of a heart valve contouring atlas
JoannaSochaabAnnaRygielskacBeataUziębło-ŻyczkowskadJustynaChałubińska-FendleraAgnieszkaJurekdMałgorzataMaciorowskadMartaMielniczukdPawełPawłowskiaDobromiraTyc-SzczepaniakaPawełKrzesińskidLucynaKepkaa
Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy
ShivaniKumarabcLoisHollowayabcdefMiriamBoxeragMei LingYapabchiPhillipChlapabcDanielMosesjkShaliniVinodabc
Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation
Amar U.KishanabNicholasMarcocMelanie-BirteSchulz-JaavalldMichael L.SteinbergaPhuoc T.TraneJesus E.JuarezaAudreyDangaDonatelloTelescacWolfgang A.LillebydJoanne B.Weidhaasa
Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment
Rasmus LübeckChristiansenabLarsDysagercChristian RønnHansenabHenrik RobenhagenJensenbTineSchytteacChristina JunkerNyborgcAnders SmedegaardBertelsenbSøren NielsenAgergaardbFaisalMahmoodabSteinbjørnHansencOlfredHansenacCarstenBrinkabUffeBernchouab
LITE SABR M1: Planning design and dosimetric endpoints for a phase I trial of lattice SBRT
James A.KavanaughMatthew B.SprakerSaiDurisetiFrancoBasarabescuAlexPriceMurtyGodduNelsKnutsonMichaelPrusatorCliffordRobinsonThomasMazur
Technical feasibility and clinical evaluation of 4D-MRI guided liver SBRT on the MR-linac
T.N.van de Lindt1M.E.Nowee1T.JanssenC.SchneiderP.RemeijerV.W.J.van PeltA.BetgenE.P.M.JansenJ.J.Sonke
Distinct lipid profiles of radiation-induced carotid plaques from atherosclerotic carotid plaques revealed by UPLC-QTOF-MS and DESI–MSI
WeiLiabi1TaoWanga1XiaoZhanga1JungeZhucXu-YingLicFangdaPengdJingDaidJiyueWangbLiyongZhangbYabingWangaXianyangChenefTengXueegChunguangDingdChaodongWangchLiqunJiaoaij
In vivo validation and tissue sparing factor for acute damage of pencil beam scanning proton FLASH
BritaSingers SørensenabMateuszKrzysztof SitarzaChristinaAnkjærgaardcJacobJohansenaClaus EAndersencEleniKanoutaaCathrineOvergaardbCaiGrauaPerPoulsenad
Platelet glycoprotein Ibα provides radiation protection
AdamCorkenaSanchita P.GhoshcRuofeiDudMarjanBoermabJerryWareaRupakPathakb
Deep learning radiomics model related with genomics phenotypes for lymph node metastasis prediction in colorectal cancer
JiaojiaoZhaoa1HanWangb1YinZhangc1RuiWanga1QinLiuaJieLiaXueLiaHanyuHuangdJieZhangaZhaopingZengaJunZhangeZhangYibFanxinZenga
Deep learning-based GTV contouring modeling inter- and intra- observer variability in sarcomas
ThibaultMarinac1YueZhuoac1Rita MariaLahoudacFeiTianacXiaoyueMaacFangxuXingacMaryamMoteabbedabcXiaofengLiuacKiraGroggacNadyaShusharinabcJonghyeWooacRuthLimacChaoMaacYen-Lin E.ChenabcGeorgesEl Fakhriac
Landscape of mortality during and within thirty days after non-palliative radiotherapy across eleven major cancer types
MichaelXiangaAnn C.RaldowaErqi L.PollombMichael L.SteinbergaAmar U.Kishana
Trials and tribulations of bone marrow sparing radiotherapy for cervical cancer. Re: Zhou et al. Radiother Oncol. 2021;165:103–118
Loren K.Mell
Could high-dose-rate monotherapy survive beyond stereotactic ablative radiotherapy era for clinically localized prostate cancer?
HideyaYamazakiaGenSuzukiaNorihiroAibeaKojiMasuiaKenYoshidabSatoakiNakamurab
Comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India�
HamidGhaznavia1Joseph J.Bevelacquab1S.A.R.MortazavicS.M.J.MortazavidJames S.Welshef
Response to comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India�
GovindarajGanesanaSasipriyaPonniahaVivekSundarambPraveen KumarMarimuthuaVenkatramanPitchaikannuaManigandanChandrasekaranaJanakiramanThangarasucGunasekaranKannupaiyanaPrabhuRamamoorthyaBrindhaThangarajaRaguram ShreeVaishnavia
In regard to MacKay et al: FLASH radiotherapy: Considerations for multibeam and hypofractionation dose delivery
Patriciavan MarlenMaxDaheleBen J.SlotmanWilko F.A.R.Verbakel
In regard to Van Marlen: FLASH radiotherapy: Considerations for multibeam and hypofractionation dose delivery
RanaldMackayaNeilBurnetbMatthewLoweacBethanyRothwellcNormanKirkbycKarenKirkbycJolyonHendrya
